Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
As of today, Eli Lilly(LLY) shares are valued at $1,065.00. The company's market cap stands at 1.01T, with a P/E ratio of 52.64 and a dividend yield of 56.4%.
On 2026-01-24, Eli Lilly(LLY) stock moved within a range of $1,063.02 to $1,091.00. With shares now at $1,065.00, the stock is trading +0.2% above its intraday low and -2.4% below the session's peak.
Trading volume for Eli Lilly(LLY) stock has reached 2.59M, versus its average volume of 2.83M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
LLY News
If you have ever wondered whether Eli Lilly shares are priced for perfection or still offer room for value, this article is written with you in mind. The stock...
Advertisement AI partnerships put Schrödinger (SDGR) in focus Schrödinger (SDGR) has moved into the spotlight after a multi-year agreement with Manas AI for d...
Eli Lilly's valuation has been driven higher by investor excitement around GLP-1 drugs, leaving other drugmakers languishing. Over short periods, Wall Street i...
Analyst ratings
80%
of 30 ratingsMore LLY News
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium Study Overview This Phase 3 study from Eli Li...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium Study Overview This Eli Lilly Phase 1 study,...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium Unlock hedge fund-level data and powerful invest...
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. The VanEck Pharm...
Why Eli Lilly Is The IBD Stock Of The Day — Again — As Its Novo Nordisk Rivalry Deepens 1/21/2026 Eli Lilly is Wednesday's IBD Stock Of The Day. Lilly shares a...
Wall Street brokerage Bernstein sees Eli Lilly’s (LLY) stock hitting $1,300 per share. Claim 50% Off TipRanks Premium Analysts at Bernstein have reiterated a...
Eli Lilly (NYSE:LLY) received FDA Breakthrough Therapy designation for sofetabart mipitecan in platinum resistant ovarian cancer. The company also announced ne...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.